Gene and Cell Therapy: New Findings from Medical Research and Treatment

Dear Colleagues,

Gene and cell therapies could be employed to treat single-gene disorders, polygenic disorders, various forms of cancer, vascular diseases, neurodegenerative disorders, inflammatory conditions, and acquired diseases. This may promote the development of precision medicine and transform traditional medicine. Personalized treatment plans can be formulated by considering the optimal treatment effect according to the genes, microbiome composition, environment, and lifestyle of the patient.

This Special Issue aims to present research on personalized medicine that expands our understanding of cancer biology and enables us to identify which patient populations may benefit from treatments.

We therefore welcome the submission of articles that design targeted therapeutic solutions and propose predictive biomarkers by investigating the molecular and functional properties of different cancers.

Within the field of oncology, several approaches to the targeting of cancer are available, and each are associated with distinct mechanisms of action. Recent advancements have expanded the scope and effectiveness of these therapies, improving patient outcomes by addressing critical challenges such as precision, targeting, and delivery.

The scope of this Special Issue includes, but is not limited to, the following topics:

• Immunotherapy;
• Adoptive Cell Therapy;
• Stem Cell Therapy;
• Tumor microbiome ;
• Tissue Engineering and Regenerative Medicine;
• Epigenetics and Stem Cell Biology;
• Biomarkers;
• Viral Vector;
• Bacterial Vector;
• Genome Editing;
• Oncolytic Viruses;
• RNA Therapeutics;
• Vaccines.

Dr. Lorella Tripodi
Dr. Antonio Di Stasi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Translational Medicine is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.